Welcome
Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.
Ad-hoc News
Key performance indicators and reportsVitruvia Medical AG share
| Name | Werte |
|---|---|
| WKN | A2PDWF |
| ISIN | CH0461931419 |
| Valor | CH046193141 |
| Number of shares | The share capital is CHF 1,770,143.00 and is divided into 1,770,143 registered shares, each with a nominal value of CHF 1.00. |
| Availability of shares | All registered shares are freely transferable. |
| End of fiscal year | December 31 |
| Stock exchange | Munich Stock Exchange |
| Market segment | General open market |
| Initial listing | May 11, 2021 |
Course data and key figures (as of July 23, 2021)
| Name | Werte |
|---|---|
| Last share price | EUR 13,90 |
| Difference previous day | 0,0 % |
| Previous close | EUR 13,90 |
| Open | EUR 13,90 |
| High | EUR 13,90 |
| Low | EUR 13,90 |
| Volume | - |
| Turnover | - |
| Mkt. Cap. | EUR 24,6M |
Dates
Feb 28, 2021 | Publication of annual financial statements
Mar 31, 2021 | Annual General Assembly
Management Transactions
Your contact
Markus A. Bertschin
President of the Board of Directors
T +41 (0)44 915 33 78
M +41 (0)79 233 26 09
bertschin@vitruvia-med.com
Vitruvia Medical AG
Kesselackerstrasse 18
CH-5611 Anglikon I Swiss
Torsten Cejka
Board of Directors
T +41 (0)44 915 33 78
M +49 (0) 173 887 18 11
cejka@vitruvia-med.com
Vitruvia Medical AG
Germaniastraße 18-20
12099 Berlin I Germany